RANCHO CORDOVA, Calif.,
May 7, 2019 /PRNewswire/ -- Cesca
Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated
cellular processing and autologous cell therapies for
regenerative medicine, today announced that the Company
will release its financial results for the first quarter ended
March 31, 2019 on Tuesday, May 14, 2019 after the close of
trading. A conference call and webcast will follow at
1:30 p.m. PDT/ 4:30 p.m. EDT.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international) or
1-866-605-3852 (Canada). To access
a live webcast of the call, please visit:
https://services.choruscall.com/links/kool190514.html.
A replay of the call will be available until June 4 and can be accessed by dialing
1-877-344-7529 (domestic), 1-412-317-0088 (international) or
855-669-9658 (Canada) and
referencing access code 10130653. The webcast will be available for
three months.
About Cesca Therapeutics Inc.
Cesca Therapeutics Inc. is a market leader in cell processing
technologies and autologous cell therapies for regenerative
medicine. Its device division, ThermoGenesis, develops,
commercializes and markets a full suite of solutions for automated
clinical biobanking, point-of-care applications, and automation for
immuno-oncology. The Company's automated, functionally closed
CAR-TXpress™ platform is designed to streamline the manufacturing
process for the emerging CAR-T immunotherapy market. For more
information, visit: www.thermogenesis.com and
www.cescatherapeutics.com.
Company Contact:
Cesca Therapeutics Inc.
Wendy Samford
916-858-5191
ir@cescatherapeutics.com
Investor Contact:
Rx Communications
Paula Schwartz
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/cesca-therapeutics-to-announce-financial-results-for-the-first-quarter-ended-march-31-2019-and-host-a-conference-call-on-may-14-300844912.html
SOURCE Cesca Therapeutics Inc.